DK0652767T3 - Behandling af manglende mælkedannelse hos mennesker - Google Patents

Behandling af manglende mælkedannelse hos mennesker

Info

Publication number
DK0652767T3
DK0652767T3 DK91916584T DK91916584T DK0652767T3 DK 0652767 T3 DK0652767 T3 DK 0652767T3 DK 91916584 T DK91916584 T DK 91916584T DK 91916584 T DK91916584 T DK 91916584T DK 0652767 T3 DK0652767 T3 DK 0652767T3
Authority
DK
Denmark
Prior art keywords
treatment
higf
humans
lack
relates
Prior art date
Application number
DK91916584T
Other languages
English (en)
Inventor
Peter Gluckman
Stella Ruth Milsom
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Application granted granted Critical
Publication of DK0652767T3 publication Critical patent/DK0652767T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Processing Of Solid Wastes (AREA)
  • Treatment Of Sludge (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dairy Products (AREA)
DK91916584T 1990-08-03 1991-07-19 Behandling af manglende mælkedannelse hos mennesker DK0652767T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ23476690 1990-08-03
PCT/SE1991/000503 WO1992002245A1 (en) 1990-08-03 1991-07-19 Treatment of human lactation failure

Publications (1)

Publication Number Publication Date
DK0652767T3 true DK0652767T3 (da) 2000-04-03

Family

ID=19923318

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91916584T DK0652767T3 (da) 1990-08-03 1991-07-19 Behandling af manglende mælkedannelse hos mennesker

Country Status (13)

Country Link
US (1) US5276014A (da)
EP (1) EP0652767B1 (da)
JP (1) JP3074302B2 (da)
AT (1) ATE184489T1 (da)
AU (1) AU643073B2 (da)
CA (1) CA2086754C (da)
DE (1) DE69131629T2 (da)
DK (1) DK0652767T3 (da)
ES (1) ES2138960T3 (da)
GR (1) GR3032156T3 (da)
IE (1) IE912345A1 (da)
PT (1) PT98563B (da)
WO (1) WO1992002245A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260309A (en) * 1992-06-08 1997-07-27 Pharmacia Ab Substituted For K Use of 1gf-2 for prevention or treatment of nutritional or gastrointestinal disorders and promoting neonatal growth
CN1174504A (zh) * 1993-11-09 1998-02-25 麦克公司 促进生长激素释放的哌啶、吡咯烷和六氢－1h－吖庚因
WO1996009065A1 (en) * 1994-09-21 1996-03-28 Pharmacia & Upjohn Ab Method of treating hypertension in pregnant mammals
AU4318496A (en) * 1994-12-21 1996-07-10 Auckland Uniservices Limited Enhancement of fetal growth by administration of insulin-likegrowth factor-1(IGF-1)
GR1007178B (el) * 1995-02-22 2011-01-31 Πετρομανωλακης Εμμ. Πρωραιος αγωγος σκαφους με διατομην αεροτομης.
US5622932A (en) * 1995-05-05 1997-04-22 Eli Lilly And Company IGF-1 superagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853833A (en) * 1971-04-27 1974-12-10 Hormone Res Foundation Synthetic human growth-promoting and lactogenic hormones and method of producing same
BG49718A3 (bg) * 1983-07-15 1992-01-15 Bio- Technology General Corp Метод за получаване на полипептид със супероксиддисмутазна активност
EP0193917A3 (en) * 1985-03-06 1987-09-23 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration
ES2001203A6 (es) * 1985-08-12 1988-05-01 Syntex Inc Procedimiento para preparar el polipeptido factor liberador de la hormona del crecimiento bovina
US4783524A (en) * 1985-09-17 1988-11-08 Monsanto Company Growth factors
CA1299103C (en) * 1986-03-07 1992-04-21 Robert Joseph Collier Method and compositions for increasing mammary parenchyma
IL86102A (en) * 1987-05-11 1994-04-12 Univ Tulane Alkylated growth hormone-releasing peptides and use thereof
FR2622455B1 (fr) * 1987-11-04 1991-07-12 Agronomique Inst Nat Rech Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes
US5089473A (en) * 1988-08-29 1992-02-18 Monsanto Company Somatotropin variants and their use

Also Published As

Publication number Publication date
JP3074302B2 (ja) 2000-08-07
DE69131629D1 (de) 1999-10-21
PT98563A (pt) 1992-06-30
US5276014A (en) 1994-01-04
EP0652767A1 (en) 1995-05-17
GR3032156T3 (en) 2000-04-27
CA2086754A1 (en) 1992-02-04
ATE184489T1 (de) 1999-10-15
JPH05509329A (ja) 1993-12-22
CA2086754C (en) 2000-08-29
AU643073B2 (en) 1993-11-04
PT98563B (pt) 1999-01-29
WO1992002245A1 (en) 1992-02-20
AU8510891A (en) 1992-03-02
EP0652767B1 (en) 1999-09-15
IE912345A1 (en) 1992-02-12
DE69131629T2 (de) 2000-03-09
ES2138960T3 (es) 2000-02-01

Similar Documents

Publication Publication Date Title
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
EP1201241B8 (en) Compositions containing capsaicin or capsaicin analogues and an anesthetic
ATE112684T1 (de) Verwendung von igf-ii zur behandlung von knochenkrankheiten.
BG103521A (en) Substituted pyrimidinon and pyridon compounds and methods for their application
DE3768546D1 (de) Mittel zur verabreichung von hyaluronsaeure an saeuger.
BR8603315A (pt) Processo para produzir um implante de liberacao controlada;implante usado no processo;processo para purificar e concentrar hormonio de crescimento biologicamente ativo em uma forma adequada para incorporacao em um implante para administracao subcutanea
AU2147992A (en) Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
SE8802569D0 (sv) Improvements in or relation to somatostatins
ES2102393T3 (es) Complejos de acido quinolona carboxilico--ion metalico--acido.
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
EA200400731A1 (ru) Способ и фармацевтическая композиция для непредвиденной контрацепции
ES2139081T3 (es) Composiciones farmaceuticas que contienen la hormona humana del crecimiento.
MX9701187A (es) Nuevas lactamas naftofusionadas n-substituidas.
KR927002373A (ko) 성장 호르몬 분비 활성을 갖는 폴리펩타이드 화합물
ATE184489T1 (de) Behandlung fehlender milchabsonderung beim menschen
EG19302A (en) Compound with gastric acid inhibitory effect and process for its preparation
DE69924483D1 (de) Kombinationstherapie zur behandlung von tumoren
DE3676640D1 (de) Prazosin-pirbuterol-mischung zur bronchendilatation.
IE870577L (en) Topical amide preparation
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
IE840977L (en) Pharmaceutical preparations
DE68928488D1 (de) Zusammensetzungen und verabreichungsverfahren für heilmittel
DK15088D0 (da) Antibakterielt lyofiliseret praeparat
DE59002790D1 (de) Verfahren zur Herstellung einer Galenischen Zubereitung mit optimaler Bioverfügbarkeit des Wirkstoffs 2-Hydroxy-5-methyllaurophenonoxime (HMLO).
NZ767242B2 (en) Growth differentiation factor 15 agonist compounds and methods of using the same